EULAR recommendations for the management of Behçet's syndrome: 2025 update.
Updated EULAR guidelines for rare Behçet's syndrome incorporate newer biologics, providing specialists with current evidence for a serious vasculitis with limited options.
This EULAR guideline update for Behçet's syndrome — a rare systemic vasculitis with high unmet need — provides the most current evidence-based management recommendations including newer biologic options. Guideline updates for rare diseases with limited treatment options have immediate clinical impact for specialists.
What the study was
- Study design
- Clinical practice guideline (EULAR recommendation update)
- Population
- Behçet's syndrome patients
- Category
- Other
- Maturity
- Potentially Practice-Changing
- Journal
- Annals of the Rheumatic Diseases
Why it surfaced
EULAR guideline update for a rare disease; high clinical impact for affected specialists; sentinel scan find with rare disease watchlist match.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.